South Africa Stakeholders Consultation, October 5-6 2022
MATRIX held its first stakeholder meeting in Johannesburg, South Africa on October 5-6, 2022. Below are the documents and presentations from this meeting. Photos from the meeting can be viewed here.
| Description | Date | Size |
|---|
| Consultation Agenda (Download) | 2022-10-01 | 328.49 KB |
| Participant List (Download) | 2022-10-01 | 300.52 KB |
| South Africa Stakeholder Consultation Summary and Key Comments (Download) | 2022-10-19 | 2.95 MB |
| A look at the current HIV prevention landscape (Download) | 2022-10-01 | 1.49 MB |
| MATRIX: Developing the next generation of HIV prevention products for women (Download) | 2022-10-05 | 2.18 MB |
| Understanding the Research and Development Process (Download) | 2022-10-05 | 853.03 KB |
| Conducting early phase and first-in-human studies in sub-Saharan Africa (Download) | 2022-10-05 | 560.43 KB |
| What is the TAF/EVG Fast-Dissolving Insert? (Download) | 2022-10-05 | 2.1 MB |
| MATRIX-001 Phase 1 Study of the TAF/EVG Fast-Dissolving Insert (Download) | 2022-10-05 | 599.17 KB |
| What is the one-month dapivirine vaginal film? (Download) | 2022-10-05 | 1.4 MB |
| MATRIX-002 Acceptability and Safety Study of Two Prototype Vaginal Films (Download) | 2022-10-05 | 562.87 KB |
| What is the non-ARV/nonhormonal contraceptive multipurpose vaginal ring? (Download) | 2022-10-06 | 11.23 MB |
| What is the Griffithsin Fast-Dissolving Insert? (Download) | 2022-10-06 | 9.5 MB |
| What are the Cabotegravir Dissolvable Pellet Implants and the Cabotegravir Injectable Depot? (Download) | 2022-10-06 | 2.27 MB |